Top

Published in:

01-12-2016 | Case Report

Laparoscopic Completion Pancreatectomy for Local Recurrence in the Pancreatic Remnant after Pancreaticoduodenectomy: Case Reports and Review of the Literature

Authors: Mushegh A. Sahakyan, Sheraz Yaqub, Airazat M. Kazaryan, Olaug Villanger, Audun Elnæs Berstad, Knut Jørgen Labori, Bjørn Edwin, Bård Ingvald Røsok

Published in: Journal of Gastrointestinal Cancer | Issue 4/2016

Excerpt

Completion pancreatectomy (CP) is a surgical procedure, in which the aim is to remove the remnant pancreatic tissue after initial pancreatic resection. This technique is used as a salvage procedure after pancreaticoduodenectomy (PD) in patients, experiencing severe complications of pancreatic leakage. Although some authors have proposed not to consider CP in patients with a pancreatic fistula [1], Gueroult et al. assumed that CP may represent the only means to achieve adequate control of an ongoing infection [2]. Other reports also concluded that despite of significant morbidity and mortality CP has a role in the management of post-pancreatic surgical complications and may increase survival [3, 4]. …

Büchler MW, Wagner M, Schmied BM, Uhl W, Friess H, Z’graggen K. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg. 2003;138(12):1310–4.CrossRefPubMed

Gueroult S, Parc Y, Duron F, Paye F, Parc R. Completion pancreatectomy for postoperative peritonitis after pancreaticoduodenectomy: early and late outcome. Arch Surg. 2004;139(1):16–9.CrossRefPubMed

Tamijmarane A, Ahmed I, Bhati CS, et al. Role of completion pancreatectomy as a damage control option for post-pancreatic surgical complications. Dig Surg. 2006;23(4):229–34.CrossRefPubMed

Farley DR, Schwall G, Trede M. Completion pancreatectomy for surgical complications after pancreaticoduodenectomy. Br J Surg. 1996;83(2):176–9.CrossRefPubMed

D’Amato A, Gentili V, Santella S, Boschetto A, Pronio A, Montesani C. Carcinoma of the pancreatic remnant developing after pancreaticoduodenectomy for adenocarcinoma of the head of pancreas. Chir Ital. 2002;54(4):539–44.PubMed

Dalla Valle R, Mancini C, Crafa P, Passalacqua R. Pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy. JOP. 2006;7(5):473–7.PubMed

Takamatsu S, Ban D, Irie T, et al. Resection of a cancer developing in the remnant pancreas after a pancreaticoduodenectomy for pancreas head cancer. J Gastrointest Surg. 2005;9(2):263–9.CrossRefPubMed

Wada K, Takada T, Yasuda H, Amano H, Yoshida M. A repeated pancreatectomy in the remnant pancreas 22 months after pylorus-preserving pancreatoduodenectomy for pancreatic adenocarcinoma. J Hepatobiliary Pancreat Surg. 2001;8(2):174–8.CrossRefPubMed

Koizumi M, Sata N, Kasahara N, et al. Remnant pancreatectomy for recurrent or metachronous pancreatic carcinoma detected by FDG-PET: two case reports. JOP. 2010;11(1):36–40.PubMed

10.

Ogino T, Ueda J, Sato N, et al. Repeated pancreatectomy for recurrent pancreatic carcinoma after pylorus-preserving pancreatoduodenectomy: report of two patients. Case Rep Gastroenterol. 2010;4(3):429–34.CrossRefPubMedPubMedCentral

11.

Kinoshita H, Yamade N, Nakai H, et al. Successful resection of pancreatic carcinoma recurrence in the remnant pancreas after a pancreaticoduodenectomy. Hepatogastroenterology. 2011;58(109):1406–8. doi:10.5754/hge09366.CrossRefPubMed

12.

Shimoike N, Fujikawa T, Maekawa H, Tanaka A. Aggressive secondary surgery for local recurrence of pancreatic cancer. BMJ Case Rep. 2013. doi:10.1136/bcr-2013-009914.PubMedPubMedCentral

13.

Zacharias T, Oussoultzoglou E, Jaeck D, Pessaux P, Bachellier P. Surgery for recurrence of periampullary malignancies. J Gastrointest Surg. 2009;13(4):760–7. doi:10.1007/s11605-008-0769-3.CrossRefPubMed

14.

Marangos IP, Buanes T, Røsok BI, et al. Laparoscopic resection of exocrine carcinoma in central and distal pancreas results in a high rate of radical resections and long postoperative survival. Surgery. 2012;151(5):717–23. doi:10.1016/j.surg.2011.12.016.CrossRefPubMed

15.

Distler M, Rückert F, Hunger M, et al. Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma. BMC Surg. 2013;13:12. doi:10.1186/1471-2482-13-12.[PMID:23607915].CrossRefPubMedPubMedCentral

16.

Kleeff J, Reiser C, Hinz U, et al. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg. 2007;245(4):566–72.CrossRefPubMedPubMedCentral

17.

Fischer R, Breidert M, Keck T, Makowiec F, Lohrmann C, Harder J. Early recurrence of pancreatic cancer after resection and during adjuvant chemotherapy. Saudi J Gastroenterol. 2012;18(2):118–21. doi:10.4103/1319-3767.93815.CrossRefPubMedPubMedCentral

18.

Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–77.CrossRefPubMed

19.

Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg. 2007;31(2):337–42. discussion 343–4.CrossRefPubMed

20.

Hsu HP, Shan YS, Hsieh YH, Yang TM, Lin PW. Predictors of recurrence after pancreaticoduodenectomy in ampullary cancer: comparison between non-, early and late recurrence. J Formos Med Assoc. 2007;106(6):432–43.CrossRefPubMed

21.

Strobel O, Hartwig W, Hackert T, et al. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol. 2013;20(3):964–72. doi:10.1245/s10434-012-2762-z.CrossRefPubMed

22.

Lavu H, Nowcid LJ, Klinge MJ, et al. Reoperative completion pancreatectomy for suspected malignant disease of the pancreas. J Surg Res. 2011;170(1):89–95. doi:10.1016/j.jss.2011.04.050.CrossRefPubMed

23.

Müller MW, Friess H, Kleeff J, et al. Is there still a role for total pancreatectomy? Ann Surg. 2007;246(6):966–74. discussion 974–5.CrossRefPubMed

24.

Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery. 2011;149(1):79–86. doi:10.1016/j.surg.2010.04.007.CrossRefPubMed

25.

Miura F, Takada T, Amano H, et al. Repeated pancreatectomy after pancreatoduodenectomy. J Gastrointest Surg. 2007;11(2):179–86.CrossRefPubMed

26.

Miyazaki M, Yoshitomi H, Shimizu H, et al. Repeat pancreatectomy for pancreatic ductal cancer recurrence in the remnant pancreas after initial pancreatectomy: is it worthwhile? Surgery. 2014;155(1):58–66. doi:10.1016/j.surg.2013.06.050.CrossRefPubMed

27.

Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW et al.. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg.2012; 1696–704. doi: 10.1007/s11605-012-1912-8.

28.

Zhang T, Du X, Zhao Y. Laparoscopic surgery for pancreatic lesions: current status and future. Front Med. 2011;5(3):277–82. doi:10.1007/s11684-011-0147-5.CrossRefPubMed

29.

Røsok BI, Marangos IP, Kazaryan AM, et al. Single-centre experience of laparoscopic pancreatic surgery. Br J Surg. 2010;97(6):902–9. doi:10.1002/bjs.7020.[PMID:20474000].CrossRefPubMed

Title: Laparoscopic Completion Pancreatectomy for Local Recurrence in the Pancreatic Remnant after Pancreaticoduodenectomy: Case Reports and Review of the Literature
Authors: Mushegh A. Sahakyan
Sheraz Yaqub
Airazat M. Kazaryan
Olaug Villanger
Audun Elnæs Berstad
Knut Jørgen Labori
Bjørn Edwin
Bård Ingvald Røsok
Publication date: 01-12-2016
Publisher: Springer US
Published in: Journal of Gastrointestinal Cancer / Issue 4/2016
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-015-9796-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Laparoscopic Completion Pancreatectomy for Local Recurrence in the Pancreatic Remnant after Pancreaticoduodenectomy: Case Reports and Review of the Literature

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2016

Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan

Rare Giant Pedunculated Liposarcoma of the Hypopharynx: Case Report and Review of Literature

Giant Gastric Liposarcoma: A Fatal Exceptional Location

Mycosis Fungoides of the Rectum: Case Report and Review of the Literature

Primary Malignant Melanoma of the Rectum: a Case Report of an Extremely Rare Gastrointestinal Cancer

Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page